This polyclonal antibody was generated against a purified His-tagged 15 kDa fragment of CPD (second half of the first, N-terminal carboxypeptidase domain) expressed in E. Coli and is specific for the C-terminal half of human CPD Domain 1.
Carboxypeptidase D (CPD) is a membrane glycoprotein with a single hydrophobic transmembrane anchor near the C-terminus and three tandem carboxypeptidase homology domains. Domains 1 and 2 are catalytically active but domain 3 is not. CPD cleaves only C-terminal Arg or Lys residues from proteins and has an acidic pH optimum of ~ 6.0. CPD is ubiquitously expressed and is especially high in macrophages. CPD is predominantly localized in the trans-Golgi and is involved in peptide and protein processing in the constitutive secretory pathway after initial furin cleavage and is also involved in processing microbial toxins such as Pseudomonas exotoxin. Drosophila lacking CPD die in the larval stage and CPD is an important target gene of TGF-ß in macrophages that is downregulated in lupus erythematosus. CPD-mediated generation of L-Arg enhances iNOS-dependent NO generation in mouse macrophages and promote NO production and cell survival in breast cancer cells.
From the laboratory of Randal A. Skidgel, PhD, University of Illinois at Chicago.
Part of The Investigator's Annexe program.
|Antigen:||Carboxypeptidase D (CPD)|
|Molecular Weight:||180 kDa|
|Reactivity:||Human (other species not tested)|
|Immunogen:||purified His-tagged 15 kDa fragment of CPD (second half of the first, N-terminal carboxypeptidase domain) expressed in E. Coli|
|Epitope:||CPD domain 1, C-terminal half|
|Tested Applications:||WB (1:1000)|
If you publish research with this product, please let us know so we can cite your paper.